Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome

Averna, M.; Missault, L.; Vaverkova, H.; Farnier, M.; Viigimaa, M.; Dong, Q.; Shah, A.; Johnson-Levonas, A.O.; Taggart, W.; Brudi, P. (2011). Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome. Diabetes and Vascular Disease Research, 8, 262−270.1479164111418136.
ajakirjaartikkel
Averna, M.; Missault, L.; Vaverkova, H.; Farnier, M.; Viigimaa, M.; Dong, Q.; Shah, A.; Johnson-Levonas, A.O.; Taggart, W.; Brudi, P.
  • English
Diabetes and Vascular Disease Research
1479-1641
8
4
2011
262270
Ilmunud
1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
SCOPUS

Viited terviktekstile

10.1177/1479164111418136

Seotud asutused

Lisainfo

Export Date: 27 October 2017
Scopus